NCT00034216 2026-04-21
Collection of Blood From Patients With Cancer
National Institutes of Health Clinical Center (CC)
Recruiting
Clinical Trials
1,238 trialsNCT04145141 2026-04-21
National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer
National Institutes of Health Clinical Center (CC)
Active not recruiting
NCT05486572 2026-04-21
PREMIUM
VA Office of Research and Development
Phase NA Recruiting
NCT06486454 2026-04-21
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
HistoSonics, Inc.
Recruiting
NCT07227012 2026-04-20
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Pfizer
Phase 1/2 Recruiting
NCT00373347 2026-04-17
Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
Stanford University
Completed
NCT02954094 2026-04-17
A Longitudinal Observational Study of the Natural History and Management of Patients With HCC
Target PharmaSolutions, Inc.
Active not recruiting
NCT04107766 2026-04-17
NOLA (NeuWave Observational Liver Ablation) Registry
Ethicon, Inc.
Terminated
NCT06855225 2026-04-17
A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma
Hoosier Cancer Research Network
Phase 2 Not yet recruiting
NCT07537205 2026-04-17
The Effects of a Nurse-led TGA-based Pre-rehabilitation Planning on Perioperative Outcomes in Patients With Liver Cancer: Study and Protocol
Fudan University
Phase NA Enrolling by invitation
NCT03778957 2026-04-15
EMERALD-1
AstraZeneca
Phase 3 Active not recruiting
NCT06091930 2026-04-14
A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Boehringer Ingelheim
Phase 1 Active not recruiting
NCT07265544 2026-04-14
Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease
Nanfang Hospital, Southern Medical University
Recruiting
NCT02381561 2026-04-13
Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy
National Cancer Institute (NCI)
Phase 1 Active not recruiting
NCT05211323 2026-04-13
A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT06362369 2026-04-13
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
Phase 1/2 Recruiting
NCT06679985 2026-04-13
A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma
Coherus Oncology, Inc.
Phase 2 Active not recruiting
NCT06753136 2026-04-13
Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype
Istituto Oncologico Veneto IRCCS
Phase NA Recruiting
NCT07192172 2026-04-13
ERFA
Seoul National University Hospital
Phase NA Completed
NCT07517198 2026-04-08
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Exscientia AI Limited
Phase 1 Recruiting
NCT00451022 2026-04-07
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
National Institutes of Health Clinical Center (CC)
Recruiting
NCT05003895 2026-04-07
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
National Institutes of Health Clinical Center (CC)
Phase 1 Recruiting
NCT05301842 2026-04-07
EMERALD-3
AstraZeneca
Phase 3 Active not recruiting
NCT04715191 2026-04-06
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Baylor College of Medicine
Phase 1 Recruiting
NCT06096779 2026-04-03
Kirros
Genentech, Inc.
Phase 2 Recruiting
NCT06342414 2026-04-03
ELUCIDATE
City of Hope Medical Center
Recruiting
NCT06600321 2026-03-31
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Alnylam Pharmaceuticals
Phase 1 Recruiting
NCT07124000 2026-03-31
DP-04
AstraZeneca
Recruiting
NCT07504367 2026-03-31
Large Language Models Assist in Tumor MDT
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase NA Recruiting
NCT03408665 2026-03-30
STEREOLIVER
Centre Oscar Lambret
Phase NA Active not recruiting
NCT04620538 2026-03-30
VOCAL
Imperial College London
Completed
NCT07312292 2026-03-30
RADIANT
UMC Utrecht
Phase 2 Recruiting
NCT07377487 2026-03-30
INDIGO
Boston Scientific Corporation
Phase NA Recruiting
NCT07500220 2026-03-30
DUET-HCC
Beijing Biotech
Phase 1/2 Recruiting
NCT04390724 2026-03-27
Optimizing Y90 Therapy for Radiation Lobectomy
Northwestern University
Recruiting
NCT05063565 2026-03-27
ROWAN
Boston Scientific Corporation
Phase 2 Active not recruiting
NCT05622136 2026-03-27
STRAT-aHCC
Instituto do Cancer do Estado de São Paulo
Phase 2 Active not recruiting
NCT06687941 2026-03-27
A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors
Aptamer Sciences, Inc.
Phase 1 Recruiting
NCT06447064 2026-03-25
(CLOCS-2)
Imperial College London
Recruiting
NCT06858813 2026-03-25
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
AbbVie
Phase 1 Recruiting
NCT03937830 2026-03-24
Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma
National Institutes of Health Clinical Center (CC)
Phase 2 Active not recruiting
NCT04008797 2026-03-24
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor
Eisai Inc.
Phase 1/2 Active not recruiting
NCT05240040 2026-03-23
Treat Primary and Metastatic Liver Tumors
Methodist Health System
Withdrawn
NCT06345508 2026-03-20
QUS in HCC
Centre hospitalier de l'Université de Montréal (CHUM)
Recruiting
NCT05128032 2026-03-19
PEDIR
Massachusetts General Hospital
Phase NA Active not recruiting
NCT05411133 2026-03-19
Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients
Arbele Limited
Phase 1 Completed
NCT06040099 2026-03-19
EMERALD-Y90
AstraZeneca
Phase 2 Active not recruiting
NCT07044362 2026-03-19
Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis
Case Comprehensive Cancer Center
Phase NA Recruiting
NCT05359861 2026-03-18
Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma
Coherus Oncology, Inc.
Phase 2 Completed
NCT07473687 2026-03-16
IBPM
Taipei Veterans General Hospital, Taiwan
Recruiting